Chison Medical Technologies Co., Ltd. (SHA:688358)
30.01
-0.09 (-0.30%)
Aug 14, 2026, 3:00 PM CST
SHA:688358 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 435.38 | 435.81 | 468.7 | 483.84 | 380.84 | 397.81 |
Revenue Growth | -4.48% | -7.02% | -3.13% | 27.05% | -4.26% | 19.43% |
Gross Profit Gross Profit Growth | 252.57 | 253.24 | 271.75 | 275.5 | 220.24 | 218.92 |
Operating Income Operating Income Growth | 95.32 | 88.26 | 100.47 | 114.02 | 66.22 | 72.24 |
Net Income Net Income Growth | 120.91 | 116.5 | 140.51 | 146.48 | 105.84 | 112.47 |
Earnings Per Share EPS Growth | 1.08 | 1.04 | 1.26 | 1.33 | 0.94 | 1.00 |
EPS Growth | -11.55% | -17.46% | -5.26% | 41.49% | -6.00% | 12.00% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 39.17 |
Overseas Overseas Growth | 396.43 |
Total Total Growth | 435.6 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,005 | 1,068 | 1,101 | 1,029 | 1,027 | 1,026 |
Total Debt Total Debt Growth | 6.49 | 3.14 | 6.53 | 10.34 | 6.11 | 1.37 |
Net Cash (Debt) Net Cash Growth | 998.24 | 1,064 | 1,094 | 1,019 | 1,021 | 1,025 |
Net Cash Growth | -10.57% | -2.72% | 7.39% | -0.21% | -0.37% | -2.11% |
Net Cash Per Share Net Cash Per Share Growth | 8.92 | 9.50 | 9.81 | 9.25 | 9.07 | 9.11 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 69.23 | 107.17 | 140.68 | 85.91 | 63.74 | 39.96 |
Capital Expenditures CapEx Growth | -15.19 | -14.41 | -8.85 | -34.01 | -52.21 | -39.19 |
Free Cash Flow Free Cash Flow Growth | 54.04 | 92.76 | 131.83 | 51.9 | 11.53 | 0.78 |
Free Cash Flow Growth | -57.38% | -29.64% | 154.02% | 350.04% | 1386.91% | -98.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 58.01% | 58.11% | 57.98% | 56.94% | 57.83% | 55.03% |
Operating Margin | 21.89% | 20.25% | 21.44% | 23.57% | 17.39% | 18.16% |
Pretax Margin | 30.25% | 29.52% | 33.46% | 33.52% | 30.23% | 31.31% |
Profit Margin | 27.77% | 26.73% | 29.98% | 30.28% | 27.79% | 28.27% |
FCF Margin | 12.41% | 21.29% | 28.13% | 10.73% | 3.03% | 0.19% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 1.160 | 0.880 | 1.000 | 0.800 | 0.700 | 0.357 |
Dividend Per Share Growth | -12.00% | -12.00% | 25.00% | 14.29% | 96.02% | -37.50% |
Dividend Yield | 3.85% | 3.00% | 4.35% | 2.32% | 2.27% | 1.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 27.79 | 28.91 | 19.49 | 28.92 | 36.44 | 32.42 |
Forward PE | 19.11 | 19.77 | 12.33 | 19.26 | - | - |
P/FCF Ratio | 62.26 | 36.30 | 20.77 | 81.62 | 334.47 | 4701.59 |
PS Ratio | 7.73 | 7.73 | 5.84 | 8.76 | 10.13 | 9.17 |